Article Versions Notes

Wang Y, Liang Y, Cheung MH, Wang X, Mo H, Gan J, Yang W, Guo J, Liang C. The ErChen Decoction and Its Active Compounds Ameliorate Non-Alcoholic Fatty Liver Disease Through Activation of the AMPK Signaling Pathway. Pharmaceuticals. 2025; 18(11):1707. https://doi.org/10.3390/ph18111707

Wang, Ye, Yanting Liang, Man Hei Cheung, Xinran Wang, Huimei Mo, Jiehua Gan, Wei Yang, Jianmin Guo, and Chun Liang. 2025. "The ErChen Decoction and Its Active Compounds Ameliorate Non-Alcoholic Fatty Liver Disease Through Activation of the AMPK Signaling Pathway" Pharmaceuticals 18, no. 11: 1707. https://doi.org/10.3390/ph18111707

Wang, Y., Liang, Y., Cheung, M. H., Wang, X., Mo, H., Gan, J., Yang, W., Guo, J., & Liang, C. (2025). The ErChen Decoction and Its Active Compounds Ameliorate Non-Alcoholic Fatty Liver Disease Through Activation of the AMPK Signaling Pathway. Pharmaceuticals, 18(11), 1707. https://doi.org/10.3390/ph18111707